Hepatitis A in the Eastern Mediterranean Region: a comprehensive review

References

• World Health Organization. The immunological basis for immunization series: module 18: hepatitis A; 2011 [accessed 2021 Feb 21]. https://apps.who.int/iris/handle/10665/44570
   Google Scholar
• World Health Organization. WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec. 2012;87(28/29):261–17.
   PubMedGoogle Scholar
• Foster MA, Penina Haber P, Nelson NP, Hepatitis A. In: Hamborsky J, Kroger A, Wolfe Seditors, Epidemiology and prevention of vaccine-preventable diseases, 13. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepa.pdf: Center for Disease Control and Prevention. Washington DC: Public Health Foundation;2015, pp. 125–42
   Google Scholar
• Wolff MH, Schmidt A. Hepatitis A infection. In: Weber O, and Protzer U, editors. Comparative hepatitis. Basel: Birkhäuser Basel; 2008. p. 121–34.
   Google Scholar
• Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2018;68(1):167–84. doi:10.1016/j.jhep.2017.08.034.
   Web of Science ®Google Scholar
• Lolekha S, Pratuangtham S, Punpanich W, Bowonkiratikachorn P, Chimabutra K, Weber F. Immunogenicity and safety of two doses of a paediatric hepatitisA vaccine in thai children: comparison of three vaccination schedules. J Trop Pediatr. 2003;49(6):333–39. doi:10.1093/tropej/49.6.333.
   PubMed Web of Science ®Google Scholar
• Raczniak GA, Bulkow LR, Bruce MG, Zanis CL, Baum RL, Snowball MM, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ, et al. Long-Term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series. J Infect Dis. 2013;207(3):493–96. doi:10.1093/infdis/jis710.
   PubMed Web of Science ®Google Scholar
• Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ, et al. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up. Hepatology. 2012;56(2):516–22. doi:10.1002/hep.25687.
   PubMed Web of Science ®Google Scholar
• Itani T, Jacobsen KH, Nguyen T, Wiktor SZ. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region. Vaccine. 2014;32(46):6067–74. doi:10.1016/j.vaccine.2014.09.006.
   PubMed Web of Science ®Google Scholar
• Koroglu M, Jacobsen, KH, Demiray T, Ozbek A, Erkorkzam U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017;10(5):513–17. doi:10.1016/j.jiph.2016.09.020.
   PubMed Web of Science ®Google Scholar
• Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011;10(1):57. doi:10.1186/1476-072X-10-57.
   PubMedGoogle Scholar
• World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility : a systematic review. WHO/IVB/10.012.010; 2010 [accessed 2020 Nov 4]. https://apps.who.int/iris/handle/10665/70180
   Google Scholar
• World Health Organization. Regional office for the Eastern Mediterranean. [accessed 2020 Nov 4]. http://www.emro.who.int/countries.html
   Google Scholar
• The World Bank. World Bank country and lending groups. [accessed 2020 Nov 4]. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
   Google Scholar
• Aljouni K, Al-Mazrou YY, Ammar WS, Daar AS, Daulaire N, Ezzati M, Fathalla M, Houssin DP, Kickbusch I, Mechbal A, et al. Refugees in the eastern Mediterranean region. Lancet. 2015;386(10012):2476–77. doi:10.1016/S0140-6736(15)01242-8.
   PubMed Web of Science ®Google Scholar
• Safiabadi M, Rezaee-Zavareh MS, Moayed Alavian S. Estimation of hepatitis A virus infection prevalence among Eastern Mediterranean and Middle Eastern countries: a systematic review and pooled analysis. Hepat Mon. 2017;17(2):e44695. doi:10.5812/hepatmon.44695.
   Web of Science ®Google Scholar
• Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–57. doi:10.1016/j.vaccine.2010.08.037.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;6:e1000097.
   Google Scholar
• Abdo AA, Sanai FM. Viral hepatitis in Saudi Arabia. An unfinished story. Saudi Med J. 2015;36(7):785–86. doi:10.15537/smj.2015.7.12457.
   PubMed Web of Science ®Google Scholar
• Abdo AA, Sanai FM, Al-Faleh FZ. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook? Saudi J Gastroenterol. 2012;18(6):349–57. doi:10.4103/1319-3767.103425.
   PubMed Web of Science ®Google Scholar
• Al Faleh F, Al Shehri S, Al Ansari S, Jeffri MA, Mazrou YA, Shaffi A, Abdo AA. Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol. 2008;14(48):7371–75. doi:10.3748/wjg.14.7371.
   PubMed Web of Science ®Google Scholar
• Al Faleh FZ, Ali S, Aljebreen AM, Alhammad E, Abdo AA. Seroprevalence rates of Helicobacter pylori and viral hepatitis A among adolescents in three regions of the Kingdom of Saudi Arabia: is there any correlation? Helicobacter. 2010;15(6):532–37. doi:10.1111/j.1523-5378.2010.00800.x.
   PubMed Web of Science ®Google Scholar
• Al Rashed RS. Prevalence of hepatitis A virus among Saudi Arabian children: a community-based study. Ann Saudi Med. 1997;17(2):200–03. doi:10.5144/0256-4947.1997.200.
   PubMed Web of Science ®Google Scholar
• Al-Faleh F, Al-Jeffri M, Ramia S, Al-Rashed RS, Arif MA, Mohammed OM, Bakhsh MH, Al-Freihi HM, Aljumah AA, Rezeig MA, et al. Hepatitis A in Saudi Arabia: a comparative sero-epidemiological study. Saudi Med J. 1999;20(9):678–81.
   PubMed Web of Science ®Google Scholar
• Al-Faleh FZ. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med. 2003;23:367–71.
   PubMed Web of Science ®Google Scholar
• Alghamdi A, Khalil M, Alyahia O. Serological approach to need assessment for hepatitis A vaccination in primary schools in Al-Qassim. King AbdulAziz City for Science and Technology; 2004 [accessed 2020 Nov 4]. https://www.researchgate.net/publication/266949043_Serological_approach_to_need_assessment_for_hepatitis_A_vaccination_in_primary_schools_in_Al-Qassim
   Google Scholar
• Al-Knawy B, El-Mekki AA, Yarbough PO. The Role of Hepatitis E Virus Infection among patients with acute viral hepatitis in Southern Saudi Arabia. Ann Saudi Med. 1997;17(1):32–34. doi:10.5144/0256-4947.1997.32.
   PubMed Web of Science ®Google Scholar
• Al-Majed SA, Bakir TM, Al-Aska A, Ayoola B. An outbreak of acute hepatitis A infection in rural Saudi Arabia. Trop Gastroenterol. 1990;11:202–05.
   PubMedGoogle Scholar
• Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol. 2006;27(11):1178–83. doi:10.1086/508826.
   PubMed Web of Science ®Google Scholar
• Almuneef MA, Memish ZA, Balkhy HH, Qahtani M, AlOtaibi B, Hajeer A, Qasim L, Al Knawy B. Epidemiologic shift in the prevalence of hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination. Vaccine. 2006;24(27–28):5599–603. doi:10.1016/j.vaccine.2006.04.038.
   PubMed Web of Science ®Google Scholar
• Alshabanat A, Albacker R, Basalamah A, Salamah A, Al-Frayh A. Profile of viral hepatitis in Saudi Arabia. Biomed Res. 2013;24:396–99.
   Google Scholar
• Al-Tawfiq JA, Anani A. Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit. 2008;14:Cr52–6.
   PubMed Web of Science ®Google Scholar
• Arif M. Enterically transmitted hepatitis in Saudi Arabia: an epidemiological study. Ann Trop Med Parasitol. 1996;90(2):197–201. doi:10.1080/00034983.1996.11813044.
   PubMed Web of Science ®Google Scholar
• Arif M, Al-Faleh FZ, Al-Frayh AR, Ramia S. Reduction in the prevalence of antibody to hepatitis A virus among young Saudi adults: implications for hepatitis A vaccine. Saudi J Gastroenterol. 1995;1:93–96.
   PubMedGoogle Scholar
• Ashraf SJ, Arya SC, Parande CM. Viral hepatitis markers in patients on haemodialysis in a hyperendemic area. J Med Virol. 1986;19(1):41–46. doi:10.1002/jmv.1890190107.
   PubMed Web of Science ®Google Scholar
• Ashraf SJ, Arya SC, Parande CM, Kristensen E. Hepatitis A virus among natives and expatriates in Saudia Arabia. J Med Virol. 1986;19(2):151–53. doi:10.1002/jmv.1890190207.
   PubMed Web of Science ®Google Scholar
• Ayoola A, Aderoju A, Gadour MO, Al-Hazmi M, Hamza MK, Ene D, Hafeez M, Anderson D, Riddell M. Serological profile of sporadic acute viral hepatitis in an area of hyper-endemic hepatitis B virus infection. Saudi J Gastroenterol. 2001;7:95–102.
   PubMedGoogle Scholar
• Babaeer M, Awfi MSH. Prevalence study of hepatitis A virus (HAV) on Jeddah population. Biosci Biotechnol Res Asia. 2011;8(2):585–90. doi:10.13005/bbra/903.
   Google Scholar
• El-Gilany A-H, Hammad S, Refaat K, Al-Enazi R. Seroprevalence of hepatitis A antibodies among children in a Saudi community. Asian Pac J Trop Med. 2010;3:278–82.
   Web of Science ®Google Scholar
• Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J. 2000;21:945–49.
   PubMed Web of Science ®Google Scholar
• Jaber SM. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Saudi Med J. 2006;27:1515–22.
   PubMed Web of Science ®Google Scholar
• Khalil M, Al-Mazrou Y, Al-Jeffri M, Al-Howasi M. Childhood epidemiology of hepatitis A virus in Riyadh, Saudi Arabia. Ann Saudi Med. 1998;18(1):18–21. doi:10.5144/0256-4947.1998.18.
   PubMed Web of Science ®Google Scholar
• Memish Z, Qasim L, Abed E, AlBasheer A, Aldraihim A, Knawy B, Hajeer AH. Pattern of viral hepatitis infection in a selected population from Saudi Arabia. Mil Med. 2003;168(7):565–68. doi:10.1093/milmed/168.7.565.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis. 2010;14(2):e115–20. doi:10.1016/j.ijid.2009.03.027.
   PubMed Web of Science ®Google Scholar
• Ramia S. Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi Arabia. J Infect. 1986;12(2):153–55. doi:10.1016/S0163-4453(86)93633-9.
   PubMed Web of Science ®Google Scholar
• Yohannan MD, Arif M, Ramia S. Aetiology of icteric hepatitis and fulminant hepatic failure in children and the possible predisposition to hepatic failure by sickle cell disease. Acta Paediatr Scand. 1990;79(2):201–05. doi:10.1111/j.1651-2227.1990.tb11439.x.
   PubMed Web of Science ®Google Scholar
• Alian S, Ajami A, Ghasemian R, Yadegarinia D. Age-Specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Med Health J. 2011;17(10):754–58. doi:10.26719/2011.17.10.754.
   PubMedGoogle Scholar
• Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of hepatitis A and E virus infections among healthy population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015;8(7):e19311. doi:10.5812/jjm.19311v2.
   PubMed Web of Science ®Google Scholar
• Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, Adibi P. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008;29:160–62.
   PubMedGoogle Scholar
• Bayani M, Sadeghi M, Kalantari N, Sayadmanesh A. Hepatitis A virus seropositivity in nurses and paramedical personnel at a university hospital in north Iran. Iran Red Crescent Med J. 2013;15(5):409–13. doi:10.5812/ircmj.10157.
   PubMed Web of Science ®Google Scholar
• Davoudi S, Rasoolinejad M, Jafari S, Erfanzadeh M, Foroughi M, Hajiabdolbaghi M, Mohraz M. Prevalence of hepatitis A virus infection in a HIV positive community. Acta Med Iran. 2010;48:192–95.
   PubMedGoogle Scholar
• Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, Mirmoghtadaee P, Hovsepian S, Mostafavi S-N. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014;19:S56–63.
   PubMed Web of Science ®Google Scholar
• Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, Keshvari M. Hepatitis A virus and hepatitis E virus seroprevalence among blood donors in Tehran, Iran. Hepat Mon. 2016;16(1):e32215. doi:10.5812/hepatmon.32215.
   PubMed Web of Science ®Google Scholar
• Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, Tajadini MH, Mostafavi SN. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016;144(2):291–96. doi:10.1017/S0950268815001302.
   PubMed Web of Science ®Google Scholar
• Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016;9:100–04.
   PubMedGoogle Scholar
• Jahanbakhsh F, Bagheri Amiri F, Sedaghat A, Fahimfar N, Mostafavi E. Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis among sheltered homeless adults in Tehran, 2012. Int J Health Policy Manag. 2018;7(3):225–30. doi:10.15171/ijhpm.2017.74.
   PubMed Web of Science ®Google Scholar
• Karimi A, Mortazaei S, Moradi MT. High prevalence of symptomatic hepatitis A infection in rural area of Chaharmahal VA Bakhtiari Province, Iran. J Clin Diagn Res. 2015;9(2):Dc01–3. doi:10.7860/JCDR/2015/9798.5515.
   PubMedGoogle Scholar
• Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275–78. doi:10.1023/B:EJEP.0000020345.37091.cd.
   PubMed Web of Science ®Google Scholar
• Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13:99–104.
   PubMed Web of Science ®Google Scholar
• Mirzaei J, Ziaee M, Farsad SA, Fereydooni M, Anani Sarab G, Rezvani Khorashad MR. Vaccination against hepatitis A for hemophilic patients: is it necessary? Hepat Mon. 2016;16(4):e37447. doi:10.5812/hepatmon.37447.
   PubMed Web of Science ®Google Scholar
• Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, Naghoosi H, Karayiannis P, Zali MR. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528–31. doi:10.1016/j.trstmh.2012.05.013.
   PubMed Web of Science ®Google Scholar
• Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, Qorbani M, Heshmat R, Tajadini MH, Ghaffari Hoseini S, et al. Comparison of the prevalence and risk factors of hepatitis A in 10 to 18-year-old adolescents of sixteen Iranian Provinces: the CASPIAN-III study. Hepat Mon. 2016;16(9):e36437. doi:10.5812/hepatmon.36437.
   PubMed Web of Science ®Google Scholar
• Rabiee A, Nikayin S, Hashemi SR, Mohaghegh M, Amini M, Rabiee R, Merat S. Seroprevalence of hepatitis A among students enrolled in Tehran University of Medical Sciences during 2011. Middle East J Dig Dis. 2013;5:137–40.
   PubMedGoogle Scholar
• Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, Mazdaki A, Alavian SM. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, Central Iran. Singapore Med J. 2011;52:107–12.
   PubMed Web of Science ®Google Scholar
• Roushan MRH, Bijani A, Sagheb R, Jazayeri O. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. East Mediterr Health J. 2007;13(5):1108–13. doi:10.26719/2007.13.5.1108.
   PubMedGoogle Scholar
• Saberifiroozi M, Serati AR, Taghvaee T, Marooofi GR, Shirazi KM. Prevalence of hepatitis A virus antibodies in patients with chronic liver disease in Shiraz, Iran. Indian J Gastroenterol. 2005;24:33–34.
   PubMedGoogle Scholar
• Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian A-R, Saffar H. Age-specific seroprevalence of anti-hepatitis A antibody among 1-30 years old population of Savadkuh, Mazandaran, Iran with literature review. Hepat Mon. 2012;12(5):326–32. doi:10.5812/hepatmon.6035.
   PubMed Web of Science ®Google Scholar
• Saneian H, Rahimi H, Shoaei P. Hepatitis A seropositivity among first-year students of the Medical University in Isfahan, Iran. Int J Prev Med. 2014;5:S208–12.
   PubMedGoogle Scholar
• Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N, Nokhodian Z, Foroughifar M. Seroprevalence of hepatitis A in patients with chronic hepatitis C in isfahan province. Int J Prev Med. 2012;3:S102–6.
   PubMedGoogle Scholar
• Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Ziazarifi A, Abhari Z, Eslamifar A, Khadem-Sadegh A, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010;8(3):176–79. doi:10.1016/j.tmaid.2010.02.004.
   PubMed Web of Science ®Google Scholar
• Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11:285–88.
   PubMed Web of Science ®Google Scholar
• Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, Yaran M. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: a seroprevalence study. J Res Med Sci. 2014;19:S9–s12.
   PubMed Web of Science ®Google Scholar
• Ahmadi Vasmehjani A, Javeshghani D, Baharlou R, Shayestehpour M, Mousavinasab SD, Joharinia N, Enderami SE. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran. Epidemiol Infect. 2015;143(3):534–39. doi:10.1017/S0950268814000806.
   PubMed Web of Science ®Google Scholar
• Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, Heidari B, Khoshkish S. HAV immunity in Iranian Medical Students. Hepat Mon. 2015;15(3):e26219. doi:10.5812/hepatmon.26219.
   PubMed Web of Science ®Google Scholar
• Al-Aziz AM, Awad MA. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. East Mediterr Health J. 2008;14:1028–35.
   PubMedGoogle Scholar
• Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study. Am J Trop Med Hyg. 1996;54(6):554–58. doi:10.4269/ajtmh.1996.54.554.
   PubMed Web of Science ®Google Scholar
• El-Karaksy H, El-Sayed R, El-Raziky M, El-Koofy N, Mansour S. Cost-Effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease. East Mediterr Health J. 2008;14:804–09.
   PubMedGoogle Scholar
• El-Karaksy HM, El-Hawary MI, El-Koofy NM, El-Sayed R, El-Raziky MAS, Mansour SA, Taha GM, El-Mougy F. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease. World J Gastroenterol. 2006;12(45):7337–40. doi:10.3748/wjg.v12.i45.7337.
   PubMed Web of Science ®Google Scholar
• Kamel MA, Troonen H, Kapprell HP, el-Ayady A, Miller FD. Seroepidemiology of hepatitis E virus in the Egyptian Nile Delta. J Med Virol. 1995;47(4):399–403. doi:10.1002/jmv.1890470417.
   PubMed Web of Science ®Google Scholar
• Omar AA, Hashish MH. Screening for hepatitis A virus antibodies among a disadvantaged group of preschool children in Alexandria. J Egypt Public Health Assoc. 2000;75:529–39.
   PubMedGoogle Scholar
• Salama II, Samy SM, Shaaban FA, Hassanin AI, Abou Ismail LA. Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J. 2007;13(6):1256–64. doi:10.26719/2007.13.6.1256.
   PubMedGoogle Scholar
• Darwish MA, Shaker M, Al-Kady AM. Non-A, non-B viral hepatitis in Egypt. J Egypt Public Health Assoc. 1992;67:171–79.
   PubMedGoogle Scholar
• Divizia M, Gabrieli R, Stefanoni ML, Ghazzawi EE, Kader OA, Gamil F, Sawaf GE, Sherbini EE, Saleh E, Degener AM, et al. HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol. 1999;15(7):603–09. doi:10.1023/A:1007514030062.
   PubMed Web of Science ®Google Scholar
• Eldin SS, Seddik I, Daef EA, Shata MT, Raafat M, Abdel Baky L, Nafeh MA. Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt. Egypt J Immunol. 2010;17:73–86.
   PubMedGoogle Scholar
• Fouad HM, Reyad EM, El-Din AG. Acute hepatitis A is the chief etiology of acute hepatitis in Egyptian children: a single-center study. Eur J Clin Microbiol Infect Dis. 2018;37(10):1941–47. doi:10.1007/s10096-018-3329-0.
   PubMed Web of Science ®Google Scholar
• Hasan G, Assiri A, Marzuuk N, Daef E, Abdelwahab S, Ahmed A, Mohamad I, Al-Eyadhy A, Alhaboob A, Temsah MH. Incidence and characteristics of hepatitis E virus infection in children in Assiut, Upper Egypt. J Int Med Res. 2016;44(5):1115–22. doi:10.1177/0300060516659575.
   PubMed Web of Science ®Google Scholar
• Hyams KC, McCarthy MC, Kaur M, Purdyt MA, Bradley DW, Mansour MM, Gray S, Watts DM, Carl M. Acute sporadic hepatitis E in children living in Cairo, Egypt. J Med Virol. 1992;37(4):274–77. doi:10.1002/jmv.1890370407.
   PubMed Web of Science ®Google Scholar
• Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Wahab AA, Mikhail N, El-Kafrawy S, El-Daly M, Abdel-Aziz F, Sharaf S, Mohamed MK. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis. 2006;42(5):628–33. doi:10.1086/500133.
   PubMed Web of Science ®Google Scholar
• Talaat M, Afifi S, Reaves EJ, Abu Elsood H, El-Gohary A, Refaey S, Hammad R, Abdel Fadeel M, Kandeel A. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis A virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001–17. BMC Infect Dis. 2019;19(1):159. doi:10.1186/s12879-019-3806-9.
   PubMedGoogle Scholar
• Talaat M, El-Sayed N, Kandeel A, Azab MA, Afifi S, Youssef FG, Ismael T, Hajjeh R, Mahoney FJ. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001-04. East Mediterr Health J. 2010;16(2):134–40. doi:10.26719/2010.16.2.134.
   PubMedGoogle Scholar
• Youssef A, Yano Y, El-Sayed Zaki M, Utsumi T, Hayashi Y. Characteristics of hepatitis viruses among Egyptian children with acute hepatitis. Int J Oncol. 2013;42(4):1459–65. doi:10.3892/ijo.2013.1822.
   PubMed Web of Science ®Google Scholar
• Zakaria S, Fouad R, Shaker O, Zaki S, Hashem A, Kamary SSE, Esmat G, Zakaria S. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin Infect Dis. 2007;44(4):e30–6. doi:10.1086/511074.
   PubMed Web of Science ®Google Scholar
• Zaki MS, Salama OS, Mansour FA, Hossein S. Hepatitis E virus coinfection with hepatotropic viruses in Egyptian children. J Microbiol Immunol Infect. 2008;41:254–58.
   PubMedGoogle Scholar
• Agboatwalla M, Isomura S, Miyake K, Yamashita T, Morishita T, Akram DS. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr. 1994;61(5):545–49. doi:10.1007/BF02751716.
   PubMedGoogle Scholar
• Aziz S, Muzaffar R, Hafiz S, Abbas Z, Zafar MN, Naqvi SAA, Rizvi SAUH. Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBsAg - prevalence and associated risk factors in pediatric communities of Karachi. J Coll Physicians Surg Pak. 2007;17(4):195–98.
   PubMed Web of Science ®Google Scholar
• Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, Siddiqui A, Jafri W. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002;36(2):474–78. doi:10.1053/jhep.2002.34856.
   PubMed Web of Science ®Google Scholar
• Ahmed W, Qureshi H, Arif A, Alam SE. Changing trend of viral hepatitis–“a twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi”. J Pak Med Assoc. 2010;60:86–89.
   PubMed Web of Science ®Google Scholar
• Haider Z, Khan AA, Rehman K, Janjua MI, Iqbal J, Chishti MA, Qayyum A, Hasnain S, Shahzad A. Sero-Diagnosis for viral hepatitis in 93 patients admitted with acute hepatitis in three different teaching hospitals in Lahore. J Pak Med Assoc. 1994;44:182–84.
   PubMedGoogle Scholar
• Khan A, Tanaka Y, Kurbanov F, Elkady A, Abbas Z, Azam Z, Subhan A, Razza S, Hamid S, Jafri W, et al. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol. 2011;83(4):622–29. doi:10.1002/jmv.22036.
   PubMed Web of Science ®Google Scholar
• Syed SA, Sarwari AR, Smego RA, Hamid S, Nissa T. Does infection with hepatitis A virus provide protection against hepatitis E virus? Med Hypotheses. 2003;60(3):337–39. doi:10.1016/S0306-9877(02)00399-7.
   PubMed Web of Science ®Google Scholar
• Waheed-Uz-Zaman T, Hussain AB, Hussain T, Anwar M, Ghani E, Asad U. Hepatitis A virus infection – shifting epidemiology. J Coll Physicians Surg Pak. 2006;16(1):15–18.
   PubMedGoogle Scholar
• Bizri AR, Nuwayhid IA, Hamadeh GN, Steitieh SW, Choukair AM, Musharrafieh UM. Association between hepatitis A virus and Helicobacter pylori in a developing country: the saga continues. J Gastroenterol Hepatol. 2006;21(10):1615–21. doi:10.1111/j.1440-1746.2006.04268.x.
   PubMed Web of Science ®Google Scholar
• Kalaajieh W, Rima A, Dennaoui M, Khodayry RA. Seroprevalence of hepatitis A antibodies in Lebanese children. Médecine Et Maladies Infectieuses. 2000;30(12):757–61. doi:10.1016/S0399-077X(01)80031-7.
   Web of Science ®Google Scholar
• Melhem NM, Jaffa M, Zaatari M, Awada H, Salibi NE, Ramia S. The changing pattern of hepatitis A in Lebanese adults. Int J Infect Dis. 2015;30:87–90. doi:10.1016/j.ijid.2014.10.007.
   PubMed Web of Science ®Google Scholar
• Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R. Hepatitis A in Lebanon: a changing epidemiological pattern. Am J Trop Med Hyg. 2005;73(2):453–56. doi:10.4269/ajtmh.2005.73.453.
   PubMed Web of Science ®Google Scholar
• Shamma’a MH. Acute viral hepatitis in Lebanon: evidence for a HAV-like non-A non-B hepatitis. Liver. 1984;4(1):39–44. doi:10.1111/j.1600-0676.1984.tb00905.x.
   PubMedGoogle Scholar
• Shamma’-a MH, Abu-Samra S, Salameh V, Nassar NT. The significance of anti-HAV in different population sectors in Lebanon: a comparative seroepidemiologic study. Int J Epidemiol. 1982;11(4):406–09. doi:10.1093/ije/11.4.406.
   PubMed Web of Science ®Google Scholar
• Letaief A, Kaabia N, Gaha R, Letaief A, Bousaadia A, Gaha R, Ghannem H, Jemni L. Age-Specific seroprevalence of hepatitis A among school children in central Tunisia. Am J Trop Med Hyg. 2005;73(1):40–43. doi:10.4269/ajtmh.2005.73.40.
   PubMed Web of Science ®Google Scholar
• Louati N, Feki L, Rekik H, Feki H, Chaabouni M, Hammami A, Gargouri J, Karray-Hakim H. Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007. Arch Inst Pasteur Tunis. 2009;86:69–74.
   PubMedGoogle Scholar
• Neffatti H, Lebraud P, Hottelet C, Gharbi J, Challouf T, Roque-Afonso A-M. Southern Tunisia: a still high endemicity area for hepatitis A. PLoS ONE. 2017;12(4):e0175887. doi:10.1371/journal.pone.0175887.
   PubMed Web of Science ®Google Scholar
• Rezig D, Ouneissa R, Mhiri L, Mejri S, Haddad-Boubaker S, Ben Alaya N, Triki H. Séroprévalences des infections à hépatite A et E en Tunisie. Pathol Biol. 2008;56(3):148–53. doi:10.1016/j.patbio.2007.09.026.
   PubMedGoogle Scholar
• Gharbi-Khelifi H, Abid NB, Beji A, Bhiri L, Harrath R, Sdiri K, Billaudel S, Ferre V, Aouni M. Seroprevalence and molecular characterisation of human hepatitis A virus in serum samples of Tunisian patients with clinical symptoms of viral hepatitis. Indian J Virol. 2012;23(1):29–35. doi:10.1007/s13337-012-0063-6.
   PubMedGoogle Scholar
• Hellara O, Melki W, Mastouri M, Ben Chaabène N, Loghmari H, Ben Mansour W, Bdioui F, Safer L, Saffar H. Serodiagnosis of acute hepatitis in adults patients: results of a prospective study in a central region of Tunisia. Tunis Med. 2014;92:201–07.
   PubMedGoogle Scholar
• Al-Naaimi AS, Turky AM, Khaleel HA, Jalil RW, Mekhlef OA, Kareem SA, Hasan NY, Dhadain AA. Predicting acute viral hepatitis serum markers (A and E) in patients with suspected acute viral hepatitis attending primary health care centers in Baghdad: a one year cross-sectional study. Glob J Health Sci. 2012;4(5):172–83. doi:10.5539/gjhs.v4n5p172.
   PubMedGoogle Scholar
• Marcus S, Al-Moslih M, Al-Tawil NG, Kassir ZA. Virological and immunological studies in patients with acute viral hepatitis. Scand J Immunol. 1993;37(2):265–70. doi:10.1111/j.1365-3083.1993.tb01765.x.
   PubMed Web of Science ®Google Scholar
• Rassam SW, Goudeau AM, Dubois F, Al-Khoury BN, Al-Deen JA, Sadik AM. Acute viral hepatitis: an aetiological study of 253 patients. J Gastroenterol Hepatol. 1989;4(2):151–54. doi:10.1111/j.1440-1746.1989.tb00819.x.
   PubMed Web of Science ®Google Scholar
• Turky A, Akram W, Al-Naaimi A, Omer A, Al-Rawi J. Analysis of acute viral hepatitis (A and E) in Iraq. Glob J Health Sci. 2011;3(1):70–76. doi:10.5539/gjhs.v3n1p70.
   Google Scholar
• Alkhalidi J, Alenezi B, Al-Mufti S, Hussain E, Askar H, Kemmer N, Neff GW. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol. 2009;15(1):102–05. doi:10.3748/wjg.15.102.
   PubMed Web of Science ®Google Scholar
• Al-Kandari S, Nordenfelt E, Al-Nakib B, Grover S, Al-Nakib W. Viral hepatitis and pregnancy in Kuwait. Trans R Soc Trop Med Hyg. 1987;81(3):395–97. doi:10.1016/0035-9203(87)90146-5.
   PubMed Web of Science ®Google Scholar
• Al-Kandari S, Nordenfelt E, Al-Nakib B, Al-Nakib W. Hepatitis A and B virus infections in children in Kuwait. Ann Trop Paediatr. 1986;6(2):135–39. doi:10.1080/02724936.1986.11748424.
   PubMed Web of Science ®Google Scholar
• Hassan-Kadle MA, Osman MS, Ogurtsov PP. Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study. World J Gastroenterol. 2018;24(34):3927–57. doi:10.3748/wjg.v24.i34.3927.
   PubMed Web of Science ®Google Scholar
• Bile K, Mohamud O, Aden C, Norder H, Mohamud O, Aden C, Nilsson L. The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions. Am J Trop Med Hyg. 1992;47(3):357–64. doi:10.4269/ajtmh.1992.47.357.
   PubMed Web of Science ®Google Scholar
• Mohamud KB, Aceti A, Mohamed OM, Pennica A, Maalin KA, Biondi R, Hagi MA, Quaranta G, Paparo SB, Celestino D, et al. [The circulation of the hepatitis A and B viruses in the Somali population]. Ann Ital Med Int. 1992;7(2):78–83.
   PubMedGoogle Scholar
• Fox E, Abbatte EA, Said S, Constantine NT, Wassef HH, Woody JN. Viral hepatitis markers in Djibouti: an epidemiological survey. Trans R Soc Trop Med Hyg. 1988;82(5):750–52. doi:10.1016/0035-9203(88)90225-8.
   PubMed Web of Science ®Google Scholar
• Coursaget P, Buisson Y, Enogat N, Bercion R, Baudet J-M, Delmaire P, Prigent D, Desramé J. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol. 1998;28(5):745–50. doi:10.1016/S0168-8278(98)80222-5.
   PubMed Web of Science ®Google Scholar
• Battikhi MN, Battikhi EG. The seroepidemiology of Hepatitis A virus in Amman, Jordan. New Microbiol. 2004;27:215–20.
   PubMedGoogle Scholar
• Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015;87(4):569–74. doi:10.1002/jmv.24137.
   PubMed Web of Science ®Google Scholar
• Antaki N, Kebbewar MK. Hepatitis A seroprevalence rate in Syria. Trop Doct. 2000;30(2):99–101. doi:10.1177/004947550003000215.
   PubMed Web of Science ®Google Scholar
• Al-Azmeh J, Frösner G, Darwish Z, Bashour H, Monem F. Hepatitis E in Damascus, Syria. Infection. 1999;27(3):221–23. doi:10.1007/BF02561535.
   PubMed Web of Science ®Google Scholar
• Sheek-Hussein M, Hashmey R, Alsuwaidi AR, Al Maskari F, Amiri L, Souid A-K. Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students. BMC Public Health. 2012;12(1):1047. doi:10.1186/1471-2458-12-1047.
   PubMedGoogle Scholar
• Sharar ZA, Rajah J, Parsons H. Childhood seroprevalence of hepatitis A in the United Arab Emirates. Trop Doct. 2008;38(1):65–66. doi:10.1258/td.2007.053390.
   PubMed Web of Science ®Google Scholar
• Bawazir AA, Hart CA, Sallam TA, Parry CM, Beeching NJ, Cuevas LE. Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans R Soc Trop Med Hyg. 2010;104(12):801–05. doi:10.1016/j.trstmh.2010.08.007.
   PubMed Web of Science ®Google Scholar
• Gunaid AA, Nasher TM, El-Guneid AM, Hill M, Dayton R, Pal A, Skidmore SJ, Coleman JC, Murray-Lyon IM. Acute sporadic hepatitis in the Republic of Yemen. J Med Virol. 1997;51(1):64–66. doi:10.1002/(SICI)1096-9071(199701)51:1<64::AID-JMV10>3.0.CO;2-4.
   PubMed Web of Science ®Google Scholar
• Carmoi T, Safiullah S, Nicand E. Risk of enterically transmitted hepatitis A, hepatitis E, and Plasmodium falciparum malaria in Afghanistan. Clin Infect Dis. 2009;48(12):1800. doi:10.1086/599231.
   PubMed Web of Science ®Google Scholar
• Gebreel AO, Christie AB. Viral hepatitis in children: a study in Libya. Ann Trop Paediatr. 1983;3(1):9–11. doi:10.1080/02724936.1983.11748260.
   PubMedGoogle Scholar
• Bouskraoui M, Bourrous M, Amine M. Prevalence of anti-hepatitis a virus antibodies in children in Marrakech. Arch Pediatr. 2009;16(Suppl 2):S132–6. doi:10.1016/S0929-693X(09)75317-5.
   PubMedGoogle Scholar
• Yassin K, Awad R, Tebi A, Queder A, Laaser U. The epidemiology of hepatitis A infection in Palestine: a universal vaccination programme is not yet needed. Epidemiol Infect. 2001;127(2):335–39. doi:10.1017/S0950268801005970.
   PubMed Web of Science ®Google Scholar
• Glynn MJ, Rashid A, Antao AJ, Coleman JC, Howard CR, Zuckerman AJ, Murray-Lyon IM. Imported epidemic non-A, non-B hepatitis in Qatar. J Med Virol. 1985;17(4):371–75. doi:10.1002/jmv.1890170409.
   PubMed Web of Science ®Google Scholar
• Hyams KC, Hussain MA, Al-Arabi MA, Al-Huda Atallah N, el-Tigani A, McCarthy MC. Acute sporadic hepatitis in Sudanese children. J Med Virol. 1991;33(2):73–76. doi:10.1002/jmv.1890330202.
   PubMed Web of Science ®Google Scholar
• Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med. 2018;8(10):a031716. doi:10.1101/cshperspect.a031716.
   PubMed Web of Science ®Google Scholar
• Gripenberg M, Aloysia D’Cor N, L’Azou M, Marsh G, Druelles S, Nealon J. Changing sero-epidemiology of hepatitis A in Asia Pacific countries: a systematic review. Intl J Infect Dis. 2018;68:13–17. doi:10.1016/j.ijid.2017.12.021.
   PubMed Web of Science ®Google Scholar
• Tanaka J. Hepatitis a shifting epidemiology in Latin America. Vaccine. 2000;18(Suppl 1):S57–60. doi:10.1016/S0264-410X(99)00466-1.
   PubMedGoogle Scholar
• Andani A, van Elten TM, Bunge EM, Marano C, Salgado F, Jacobsen KH. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Rev Vaccines. 2020;19(9):795–805. doi:10.1080/14760584.2020.1813575.
   PubMed Web of Science ®Google Scholar
• Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis. 2019;19(1):651. doi:10.1186/s12879-019-4235-5.
   PubMed Web of Science ®Google Scholar
• Gossner C, Severi E, Danielsson N, Hutin Y, Coulombier D. Changing hepatitis A epidemiology in the European Union: new challenges and opportunities. Euro Surveill. 2015;20(16):21101. doi:10.2807/1560-7917.ES2015.20.16.21101.
   PubMedGoogle Scholar
• Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, Wilder-Smith A, Wilson ME, Keystone JS, Schwartz E, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013;158(6):456–68. doi:10.7326/0003-4819-158-6-201303190-00005.
   PubMed Web of Science ®Google Scholar
• MacDonald E, Steens A, Stene-Johansen K, Gillesberg Lassen S, Midgley SE, Lawrence J, Crofts J, Ngui SL, Balogun K, Frank C, et al. Increase in hepatitis A in tourists from Denmark, England, Germany, the Netherlands, Norway and Sweden returning from Egypt, November 2012 to March 2013. Euro Surveill. 2013;18(17) pii=20468 doi: 10.2807/ese.18.17.20468-en.
   Google Scholar
• Gassowski M, Michaelis K, Wenzel JJ, Faber M, Figoni J, Mouna L, Friesema IH, Vennema H, Avellon A, Varela C, et al. Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018. Euro Surveill. 2018;23(27) pii=1800329 doi: 10.2807/1560-7917.ES.2018.23.27.1800329.
   PubMedGoogle Scholar
• Alwan A, Elmi M. Food safety in the Eastern Mediterranean Region: time to act. East Mediterr Health J. 2015;21(3):153–54. doi:10.26719/2015.21.3.153.
   PubMed Web of Science ®Google Scholar
• Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, Döpfer D, Fazil A, Fischer-Walker CL, Hald T, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001921. doi:10.1371/journal.pmed.1001921.
   PubMed Web of Science ®Google Scholar
• Sánchez G. Processing strategies to inactivate hepatitis A virus in food products: a critical review. Compr Rev Food Sci Food Saf. 2015;14(6):771–84. doi:10.1111/1541-4337.12154.
   Web of Science ®Google Scholar
• Gossner CM, Severi E. Three simultaneous, food-borne, multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: what does it mean for the European Union? Euro Surveill. 2014;19(43):20941. doi:10.2807/1560-7917.ES2014.19.43.20941.
   PubMedGoogle Scholar
• Swinkels HM, Kuo M, Embree G, Fraser Health Environmental Health Investigation Team C, Andonov A, Henry B, Buxton JA. Hepatitis A outbreak in British Columbia, Canada: the roles of established surveillance, consumer loyalty cards and collaboration, February to May 2012. Euro Surveill. 2014;19(18):20792. doi:10.2807/1560-7917.ES2014.19.18.20792.
   PubMedGoogle Scholar
• World Health Organization (WHO) Health emergencies. Countries in crisis; 2016 [accessed 2021 Feb 5]. http://www.emro.who.int/eha/countries-in-crisis/index.html
   Google Scholar
• Mellou K, Chrisostomou A, Sideroglou T, Georgakopoulou T, Kyritsi M, Hadjichristodoulou C, Tsiodras S. Hepatitis A among refugees, asylum seekers and migrants living in hosting facilities, Greece, April to December 2016. Euro Surveill. 2017;22(4):30448. doi:10.2807/1560-7917.ES.2017.22.4.30448.
   PubMedGoogle Scholar
• Michaelis K, Wenzel JJ, Stark K, Faber M. Hepatitis A virus infections and outbreaks in asylum seekers arriving to Germany, September 2015 to March 2016. Emerg Microbes Infect. 2017;6(4):e26. doi:10.1038/emi.2017.11.
   PubMedGoogle Scholar
• European Asylum Support Office. Latest asylum trends – 2015 overview; 2015 [accessed 2021 Feb 5]. https://www.easo.europa.eu/sites/default/files/public/LatestAsylumTrends20151.pdf
   Google Scholar
• Lee K, Worsnop CZ, Grépin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020;395(10237):1593–95. doi:10.1016/S0140-6736(20)31032-1.
   PubMed Web of Science ®Google Scholar